Skip to main content

and
  1. No Access

    Article

    Position switch of phenylthiazoles: novel compounds with promising anti-MRSA USA300

    The discovery of novel antibacterial agents holds promise in mitigating the escalating threat of antimicrobial resistance (AMR). Guided by the structure-activity relationships (SAR) of our lead compound 1 against...

    Abdelrahman A. Abuelkhir, Mariam Omara, Yosra I. Nagy in Medicinal Chemistry Research (2024)

  2. Article

    Open Access

    Exploring the antimicrobial activity of Origanum majorana L. against  the highly virulent multidrug-resistant Acinetobacter baumannii AB5075: UPLC-HRMS profiling with in vitro and in silico studies

    The infamous multidrug-resistant (MDR) bacterium Acinetobacter baumannii is becoming a nightmare in intensive care units across the globe. Since there are now very few effective antimicrobial agents, it is necess...

    Norhan H. Mahdally, Abdalla E. M. Salih in Future Journal of Pharmaceutical Sciences (2024)

  3. Article

    Open Access

    Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons

    Nanobodies are the smallest known antigen-binding molecules to date. Their small size, good tissue penetration, high stability and solubility, ease of expression, refolding ability, and negligible immunogenici...

    Soha S. Rizk, Dina M. Moustafa in World Journal of Microbiology and Biotechn… (2024)

  4. Article

    Open Access

    Evidence on the inhibitory effect of Brassica plants against Acinetobacter baumannii lipases: phytochemical analysis, in vitro, and molecular docking studies

    Infections caused by Acinetobacter baumannii are becoming a rising public health problem due to its high degree of acquired and intrinsic resistance mechanisms. Bacterial lipases penetrate and damage host tissues...

    Manal M. Sabry, Ali M. El-Halawany in BMC Complementary Medicine and Therapies (2024)

  5. Article

    Open Access

    The Moraxella catarrhalis AdhC–FghA system is important for formaldehyde detoxification and protection against pulmonary clearance

    Multidrug-resistant clinical isolates of Moraxella catarrhalis have emerged, increasing the demand for the identification of new treatment and prevention strategies. A thorough understanding of how M. catarrhalis

    Dina Othman, Noha M. Elhosseiny, Wafaa N. Eltayeb in Medical Microbiology and Immunology (2024)

  6. Article

    Open Access

    Expression and purification of hepatitis B surface antigen S from Escherichia coli; a new simple method

    Hepatitis B is a liver disease primarily caused by hepatitis B virus (HBV) infection. It is distributed worldwide and associated with high mortality and morbidity rates. HBV infections can be avoided by the ad...

    Mohamed S Elghanam, Ahmed S Attia, Hussein A Shoeb in BMC Research Notes (2012)

  7. Article

    Open Access

    Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis

    Bacteriocins are antimicrobial proteins and peptides ribosomally synthesized by some bacteria which can effect both intraspecies and interspecies killing.

    Ahmed S Attia, Jennifer L Sedillo, Todd C Hoopman, Wei Liu, Lixia Liu in BMC Microbiology (2009)